A patient with worsening hepatic encephalopathy and ascites is being considered for paracentesis. Which nursing intervention is the priority to prepare the patient for this procedure?

B) Ensuring the patient has an empty bladder to prevent puncture

A) Administering prescribed diuretics to reduce fluid retention

B) Ensuring the patient has an empty bladder to prevent puncture

C) Positioning the patient in a high Fowler's position

D) Educating the patient about the benefits and risks of the procedure

A patient with worsening hepatic encephalopathy and ascites is being considered for paracentesis and has been started on higher doses of lactulose and rifaximin. Which nursing intervention is most critical to monitor for potential complications of this treatment plan?

C) Evaluate for symptoms of infection post-paracentesis.

A) Monitor serum potassium levels closely.

B) Assess for signs of gastrointestinal bleeding.

C) Evaluate for symptoms of infection post-paracentesis.

D) Check for changes in blood glucose levels.

A patient with hepatic encephalopathy and ascites is being managed with paracentesis, lactulose, and rifaximin. Despite some improvement, the patient continues to experience peripheral edema and elevated ammonia levels. Considering the current treatment plan, which intervention should the nurse prioritize to further optimize the patient's condition?

B) Monitor and adjust diuretic therapy to address fluid retention without compromising renal function.

A) Increase the dosage of lactulose to enhance ammonia excretion.

B) Monitor and adjust diuretic therapy to address fluid retention without compromising renal function.

C) Administer supplemental oxygen to maintain oxygen saturation above 95%.

D) Implement a high-protein diet to support liver function.

A patient with cirrhosis and ascites has undergone paracentesis and reports improved breathing. However, peripheral edema persists, and vital signs show a blood pressure of 138/86 mmHg and heart rate of 102 bpm. The healthcare team is considering adjustments in diuretic therapy. Which clinical finding would most likely indicate the need to reevaluate the current diuretic regimen?

B) Worsening peripheral edema despite diuretic use

A) Increased urine output with stable renal function tests

B) Worsening peripheral edema despite diuretic use

C) Decreased blood pressure to 110/70 mmHg

D) Normalization of ammonia levels

A patient with cirrhosis is experiencing increasing confusion and disorientation. Laboratory results show elevated ammonia levels and renal impairment markers. What is the most appropriate initial nursing intervention to address these changes in the patient's condition?

A) Administer lactulose as prescribed to decrease ammonia levels.

B) Increase the dosage of spironolactone to manage fluid retention.

C) Encourage a high-protein diet to support hepatic function.

D) Initiate a fluid restriction to prevent further renal impairment.

A patient with liver cirrhosis has developed worsening hepatic encephalopathy and renal impairment. Considering the current situation, which nursing intervention is most appropriate to prioritize?

B) Administer lactulose as prescribed to reduce ammonia levels.

A) Increase protein intake to support liver function.

B) Administer lactulose as prescribed to reduce ammonia levels.

C) Encourage increased fluid intake to improve renal function.

D) Withhold diuretics to prevent further renal impairment.

A patient with cirrhosis and ascites has been diagnosed with spontaneous bacterial peritonitis (SBP) and is currently receiving intravenous cefotaxime. The nurse notes that the patient is increasingly confused and has asterixis. Which of the following nursing actions should be prioritized to address the patient's altered mental status?

B) Administer lactulose as prescribed to reduce ammonia levels.

A) Increase the dose of diuretics to reduce ascites.

B) Administer lactulose as prescribed to reduce ammonia levels.

C) Encourage oral fluid intake to prevent dehydration.

D) Monitor blood pressure closely to detect hypotension.

A patient with cirrhosis and ascites has been diagnosed with spontaneous bacterial peritonitis (SBP) and started on intravenous cefotaxime. Which nursing intervention is most critical in assessing the effectiveness of the treatment for this patient?

A) Monitoring for changes in mental status

B) Assessing daily weight and abdominal girth

C) Evaluating urine output and creatinine levels

D) Checking for signs of bleeding and bruising

A patient with spontaneous bacterial peritonitis is experiencing hypotension, increased respiratory rate, and worsening renal function. What is the priority nursing intervention to address the patient's current hemodynamic instability?

B) Administer intravenous albumin to improve renal perfusion.

A) Increase the dose of intravenous diuretics to manage ascites.

B) Administer intravenous albumin to improve renal perfusion.

C) Initiate a high-flow oxygen therapy to improve oxygen saturation.

D) Prepare the patient for a paracentesis to relieve abdominal pressure.

A patient with spontaneous bacterial peritonitis is experiencing worsening hypotension, tachycardia, and hypoxemia despite treatment. Laboratory results indicate declining renal function and worsening hepatic encephalopathy. Which of the following interventions should the nurse anticipate to optimize the patient's hemodynamic status and address these complications?

B) Administer intravenous albumin to improve renal perfusion

A) Initiate a norepinephrine infusion to manage hypotension

B) Administer intravenous albumin to improve renal perfusion

C) Increase the dose of lactulose to manage hepatic encephalopathy

D) Implement fluid restriction to prevent further renal impairment

cirrhosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Hepatocyte injury and death due to chronic liver insults (e.g., alcohol, hepatitis) trigger inflammation and activation of stellate cells, leading to excessive collagen deposition and fibrosis, disrupting normal liver architecture and function.

• Secondary mechanism: Progressive fibrosis results in portal hypertension, characterized by increased resistance to blood flow through the liver, causing complications like varices and ascites.

• Key complication: Reduced liver function due to fibrosis impairs detoxification and synthesis processes, leading to jaundice, coagulopathy, and hepatic encephalopathy.

Patient Profile

Demographics:

57-year-old male, construction worker

History:

• Key past medical history: Hepatitis C infection, alcohol use disorder (15 years, recently reduced intake), hypertension

• Current medications: Enalapril 10 mg once daily, Lactulose 30 ml twice daily, Spironolactone 100 mg once daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing abdominal discomfort and swelling

• Key symptoms: Fatigue, jaundice, mild confusion, peripheral edema, abdominal distention

• Vital signs: Blood pressure 150/90 mmHg, heart rate 98 bpm, respiratory rate 18 breaths per minute, temperature 37.3°C, oxygen saturation 95% on room air

Section 1

Change in Patient Status:

Over the next 48 hours, the patient's condition shows signs of deterioration. His abdominal distention has become more pronounced, and he complains of increased discomfort despite ongoing lactulose therapy. On examination, there is a significant increase in abdominal girth, and shifting dullness is noted, suggestive of worsening ascites. His peripheral edema has also intensified, now extending to his thighs. The patient's confusion has progressed to a level where he is disoriented to time and place, indicating potential worsening of hepatic encephalopathy.

Vital signs reveal a concerning trend: his blood pressure has dropped to 140/88 mmHg, heart rate increased to 105 bpm, and respiratory rate elevated to 22 breaths per minute, with oxygen saturation decreasing to 93% on room air. Laboratory results show a marked increase in serum bilirubin to 5.4 mg/dL, and his ammonia levels have risen to 78 µmol/L, supporting the suspicion of exacerbated hepatic encephalopathy. Liver function tests reveal further decline, with ALT and AST levels moderately elevated, while albumin has decreased to 2.8 g/dL, indicating worsening synthetic function.

This change in clinical status prompts the healthcare team to initiate a more aggressive management plan. Consideration for paracentesis is discussed to relieve ascitic pressure and improve respiratory function. The patient is also started on a higher dose of lactulose and introduced to rifaximin to target gut bacteria contributing to elevated ammonia levels. Continuous monitoring and reassessment are essential to address the evolving complications and adjust the treatment plan accordingly.

Section 2

Response to Interventions:

Over the next 24 hours, the healthcare team closely monitors the patient's response to the intensified treatment regimen. Following the paracentesis procedure, the patient reports a noticeable reduction in abdominal discomfort, and his breathing appears less labored. Approximately two liters of straw-colored fluid are removed, which temporarily alleviates the pressure symptoms and slightly improves his oxygen saturation to 95% on room air. Despite these improvements, the peripheral edema persists, particularly in the lower extremities, indicating ongoing fluid retention issues.

The increase in lactulose dosage, along with the initiation of rifaximin, begins to show positive effects on the patient's mental status. There is a slight improvement in his orientation, as he is now intermittently aware of his surroundings and able to follow simple commands. However, his ammonia levels remain elevated at 70 µmol/L, suggesting that the hepatic encephalopathy is not fully controlled yet. The healthcare team continues to emphasize the importance of medication adherence and regular monitoring of mental status to prevent further deterioration.

Despite the partial successes, the patient's blood pressure remains on the lower side at 138/86 mmHg, and his heart rate persists at 102 bpm. These vital signs, combined with the ongoing issues of edema and liver function deterioration, prompt the team to consider potential adjustments in diuretic therapy to better manage fluid status without compromising renal function. The plan includes reassessing the benefits and risks of introducing spironolactone to aid in ascites management, while also keeping a vigilant eye on electrolyte levels and renal function tests to prevent additional complications.

Section 3

New Complications:

Over the following 48 hours, the patient develops new symptoms that prompt further investigation by the healthcare team. Notably, he begins to exhibit signs of increasing confusion and disorientation, with episodes of drowsiness and difficulty maintaining attention during conversations. This change in mental status raises concerns about the progression of hepatic encephalopathy despite the current treatment regimen. The team initiates a repeat set of laboratory tests, which reveal an elevated ammonia level now at 85 µmol/L, suggesting that the encephalopathy is exacerbating, possibly due to precipitating factors that have not yet been identified or mitigated.

Additionally, the patient's renal function tests indicate a concerning rise in creatinine to 1.8 mg/dL, up from a baseline of 1.2 mg/dL, and a blood urea nitrogen (BUN) level of 35 mg/dL, indicating possible renal impairment. This change necessitates a reevaluation of the diuretic therapy, particularly the recent introduction of spironolactone, as it may be contributing to renal strain. The healthcare team considers adjusting the diuretics with a focus on optimizing the balance between effective fluid management and preserving renal function.

Concurrent with these developments, the patient starts experiencing mild jaundice, evidenced by yellowing of the sclera and skin, and his total bilirubin level is noted to have increased to 3.5 mg/dL. These findings suggest worsening liver function and highlight the need for a comprehensive review of potential triggers for hepatic decompensation, including infections, medication side effects, or dietary indiscretions. The team plans to initiate an ultrasound to assess for any hepatic or biliary abnormalities and cultures to rule out any infectious processes. Through these measures, they aim to address the underlying causes of the patient's deteriorating condition and adjust the treatment plan accordingly.

Section 4

New Diagnostic Results:

As the healthcare team delves deeper into the underlying issues contributing to the patient's deteriorating condition, they prioritize obtaining a comprehensive abdominal ultrasound and executing a series of cultures. The ultrasound reveals an increase in ascites, more pronounced since the last imaging, suggesting ongoing fluid accumulation despite diuretic therapy. Additionally, there is evidence of mild splenomegaly, a common finding in portal hypertension, which further indicates progression in the patient's cirrhotic state. Notably, the ultrasound shows no acute abnormalities in the hepatic or biliary structures, ruling out obstructions or acute cholecystitis as immediate concerns.

Simultaneously, blood cultures return positive for Escherichia coli, indicating the presence of spontaneous bacterial peritonitis (SBP), a known complication of ascites in cirrhotic patients. This diagnosis explains the recent exacerbation of hepatic encephalopathy and increasing confusion, likely due to the systemic inflammatory response. The healthcare team recognizes the urgent need to initiate antibiotic therapy to address this infection, starting with intravenous cefotaxime, a standard treatment for SBP, while monitoring the patient's clinical response closely.

These findings necessitate a reassessment of the patient's current management plan. The team discusses the possibility of further adjusting the diuretic regimen to manage ascites more effectively and contemplates the potential need for albumin supplementation to support renal perfusion and reduce the risk of hepatorenal syndrome. The focus remains on stabilizing the patient's condition by addressing both the infectious process and optimizing hepatic and renal functions, as they continue to monitor for any new complications that may arise during treatment.

Section 5

Change in Patient Status:

Despite the initiation of intravenous cefotaxime for the treatment of spontaneous bacterial peritonitis, the patient's condition shows signs of further decline over the next 48 hours. Vital signs indicate a persistent low-grade fever of 38.3°C (100.9°F), and the patient remains tachycardic with a heart rate of 102 beats per minute. Blood pressure readings are concerning, trending downwards with a current measurement of 88/56 mmHg, suggesting the onset of hypotension. Additionally, the patient exhibits increased respiratory rate at 22 breaths per minute, and oxygen saturation has dropped to 90% on room air, necessitating supplemental oxygen.

A repeat set of laboratory tests reveals worsening renal function, with serum creatinine rising to 2.1 mg/dL from a baseline of 1.3 mg/dL, indicating potential progression towards hepatorenal syndrome. Liver function tests show further elevation of bilirubin to 4.5 mg/dL and a prolonged prothrombin time (PT) of 18 seconds, highlighting impaired hepatic synthesis. The patient's mental status also deteriorates, marked by increased confusion and disorientation, consistent with worsening hepatic encephalopathy despite ongoing lactulose therapy.

In light of these developments, the healthcare team faces critical decisions. The need to optimize the patient's hemodynamic status becomes paramount, prompting consideration of intravenous albumin administration to improve renal perfusion and counteract the hypotension. Additionally, the team contemplates escalating diuretic therapy with cautious titration to manage the refractory ascites, balancing the risk of further renal impairment. The interdisciplinary approach focuses on stabilizing renal and hepatic function while closely monitoring for potential escalation of septic shock, necessitating vigilant reassessment and timely interventions.